| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Bone morphogenetic protein receptor type-1A |
|---|
| Ligand | BDBM50056676 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_1453223 (CHEMBL3365516) |
|---|
| IC50 | 1171±n/a nM |
|---|
| Citation |  Mohedas, AH; Wang, Y; Sanvitale, CE; Canning, P; Choi, S; Xing, X; Bullock, AN; Cuny, GD; Yu, PB Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants. J Med Chem57:7900-15 (2014) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Bone morphogenetic protein receptor type-1A |
|---|
| Name: | Bone morphogenetic protein receptor type-1A |
|---|
| Synonyms: | ACVRLK3 | ALK3 | Activin receptor-like kinase 3 (ALK-3) | BMPR1A | BMR1A_HUMAN |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 60204.46 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P36894 |
|---|
| Residue: | 532 |
|---|
| Sequence: | MPQLYIYIRLLGAYLFIISRVQGQNLDSMLHGTGMKSDSDQKKSENGVTLAPEDTLPFLK
CYCSGHCPDDAINNTCITNGHCFAIIEEDDQGETTLASGCMKYEGSDFQCKDSPKAQLRR
TIECCRTNLCNQYLQPTLPPVVIGPFFDGSIRWLVLLISMAVCIIAMIIFSSCFCYKHYC
KSISSRRRYNRDLEQDEAFIPVGESLKDLIDQSQSSGSGSGLPLLVQRTIAKQIQMVRQV
GKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTG
SWTQLYLITDYHENGSLYDFLKCATLDTRALLKLAYSAACGLCHLHTEIYGTQGKPAIAH
RDLKSKNILIKKNGSCCIADLGLAVKFNSDTNEVDVPLNTRVGTKRYMAPEVLDESLNKN
HFQPYIMADIYSFGLIIWEMARRCITGGIVEEYQLPYYNMVPSDPSYEDMREVVCVKRLR
PIVSNRWNSDECLRAVLKLMSECWAHNPASRLTALRIKKTLAKMVESQDVKI
|
|
|
|---|
| BDBM50056676 |
|---|
| n/a |
|---|
| Name | BDBM50056676 |
|---|
| Synonyms: | CHEMBL3341789 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C25H29N3O3 |
|---|
| Mol. Mass. | 419.5161 |
|---|
| SMILES | COc1cc(cc(OC)c1OC)-c1cc(cnc1C)-c1ccc(cc1)N1CCNCC1 |
|---|
| Structure | 
|
|---|
Search and Browse
